• FluTrackers.com Inc. does not provide medical advice. Information on this web site is collected from various internet resources, and the FluTrackers board of directors makes no warranty to the safety, efficacy, correctness or completeness of the information posted on this site by any author or poster. The information collated here is for instructional and/or discussion purposes only and is NOT intended to diagnose or treat any disease, illness, or other medical condition. Every individual reader or poster should seek advice from their personal physician/healthcare practitioner before considering or using any interventions that are discussed on this website. By continuing to access this website you agree to consult your personal physican before using any interventions posted on this website, and you agree to hold harmless FluTrackers.com Inc., the board of directors, the members, and all authors and posters for any effects from use of any medication, supplement, vitamin or other substance, device, intervention, etc. mentioned in posts on this website, or other internet venues referenced in posts on this website.
  • We are not asking for any donations. Do not donate to any entity who says they are raising funds for us.

BMC Infect Dis . Lack of association between vitamin D insufficiency and clinical outcomes of patients with COVID-19 infection

tetano

Editor, Senior Moderator
BMC Infect Dis


. 2021 May 18;21(1):450.
doi: 10.1186/s12879-021-06168-7.
Lack of association between vitamin D insufficiency and clinical outcomes of patients with COVID-19 infection


Alireza Davoudi[SUP] 1 [/SUP], Narges Najafi[SUP] 1 [/SUP], Mohsen Aarabi[SUP] 2 [/SUP], Atefeh Tayebi[SUP] 1 [/SUP], Roja Nikaeen[SUP] 3 [/SUP], Hamideh Izadyar[SUP] 1 [/SUP], Zahra Salar[SUP] 4 [/SUP], Leila Delavarian[SUP] 1 [/SUP], Narges Vaseghi[SUP] 5 [/SUP], Zahra Daftarian[SUP] 1 [/SUP], Fatemeh Ahangarkani[SUP] 6 [/SUP]



Affiliations

Abstract

Background: A protective effect of vitamin D against COVID-19 infection is under investigation. We aimed to analyze the effect of vitamin D sufficiency on the clinical outcomes of patients infected with COVID-19.
Methods: In this cross-sectional study we analyzed the vitamin D levels of COVID-19 patients who were admitted to Razi Hospital (an infectious disease referral center in Mazandaran province in northern Iran) from February to March 2020. Overall, a cutoff point of 30 ng/mL was used for the definition of vitamin D sufficiency.
Results: One hundred fifty-three patients were analyzed in this study who had laboratory documentation of a 25(OH) D level at the time of hospitalization. The vitamin D levels of the patients were 27.19 ? 20.17 ng/mL. In total, 62.7% (n = 96) of the patients had a 25(OH) D level of less than 30 ng/mL and 37.25% (n = 57) had a 25(OH) D level of more than 30 ng/mL. In total, 49% (n = 75) of the patients suffered from at least one underlying disease. The univariate and multivariable regression showed that vitamin D sufficiency was not associated with a statistically significant lower risk of adverse clinical outcomes of COVID-19 such as duration of hospitalization and severity of infection (P > 0.05).
Conclusions: Sufficient vitamin D levels were not found to be protective against adverse clinical outcomes in patients infected with COVID-19. Chronic disorders in COVID-19 patients were found to have greater relevance than vitamin D levels in determining the adverse outcomes of the infection. Further studies are needed to determine the role of vitamin D level in predicting the outcomes of COVID-19 infection.

Keywords: COVID-19; Coronavirus; Insufficiency; SARS-CoV-2; Sufficiency; Vitamin D.
 
This is a preprint and I suspect the bit in red is a typo The vitamin D levels of the patients were 27.19 ? 20.17 ng/mL.
The DOI link does not work but this one does DOI: 10.21203/rs.3.rs-121748/v1
In this version the results section now reads

Results


153 patients were analyzed in this study who had laboratory documentation of a 25(OH) D level at the time of hospitalization. In total, 62.7% (n-=96) of the patients had a 25(OH) D level of less than 30 ng/mL and 37.25% (n=57) had a 25(OH) D level of more than 30 ng/mL. In total, 49% (n=75) of the patients suffered from at least one underlying disease. Vitamin D sufficiency was not associated with a statistically significant lower risk of adverse clinical outcomes of COVID-19 such as duration of hospitalization, lung involvement, intensive care unit (ICU) admission, invasive and non-invasive ventilation, the severity of disease or death.
 
Is this a link showing the actions taken to ensure that what should be in place with regard to the vitamin D file, such as the tetanus vaccine?

There is software for such, for, depending on his skin color, suitable for general recommendations?
 
Tetano posted a study that showed that Vit D was very important in outcomes for the black patients in the study, but was not at the level used as the study's comparator in white patients. I can't find it now but it was really important research. Ignoring this truly would be a form of institutional racism.
 
Back
Top Bottom